Question 1

Has Lee Morrow received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,073,565 in general payments to Lee Morrow across 409 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Lee Morrow did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Lee Morrow come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Boehringer Ingelheim	40	$372,360
GSK	29	$150,407
United Therapeutics Corporation	47	$111,960
Shionogi Inc	16	$102,288
Merck	35	$97,563
Insmed, Inc.	37	$57,578
Novartis	3	$54,396
Chiesi USA, Inc.	17	$30,528
AstraZeneca	9	$25,154
Genentech, Inc.	2	$17,654
Boehringer Ingelheim International GmbH	73	$17,147
Roche Products Limited	3	$16,528
OPKO Pharmaceuticals, LLC	2	$9,060
Boehringer Ingelheim France S.a.s.	58	$8,612
Boehringer Ingelheim Limited	16	$1,186
Boehringer Ingelheim Pharma GmbH & Co.kg	13	$794
Astellas Pharma US Inc	4	$202
Abiomed	1	$64
Biomerieux Inc	1	$40
BD	1	$30
Janssen Research & Development, LLC	2	$12

Lee Morrow

Payments from drug & device makers

Who reported the general payments

How this compares

Other pulmonary disease in Omaha